| First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
08/12 |
16:15 |
| Ryman Hospitality Properties, Inc. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Over-Allotment Option |
Globe Newswire |
08/12 |
16:15 |
| Leslie’s, Inc. Announces Third Quarter 2026 Financial Results |
Globe Newswire |
08/12 |
16:15 |
| AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/12 |
16:15 |
| Fossil Group, Inc. Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/12 |
16:15 |
| Aptera Motors Reports Second Quarter and First Half 2026 Financial Results |
Globe Newswire |
08/12 |
16:13 |
| Gaxos Delivers Record Second-Quarter Revenue, Up 35.8% Sequentially and 1,337% Year over Year |
Globe Newswire |
08/12 |
16:10 |
| Range Impact Reports 2Q 2026 Financial Results |
Globe Newswire |
08/12 |
16:10 |
| Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million |
Globe Newswire |
08/12 |
16:10 |
| Western Announces Second Quarter 2026 Results |
Globe Newswire |
08/12 |
16:08 |
| Global Crossing Airlines Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/12 |
16:05 |
| Comscore Reports Second Quarter 2026 Results |
Globe Newswire |
08/12 |
16:05 |
| Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update |
Globe Newswire |
08/12 |
16:05 |
| Coherent Corp. Reports Fourth Quarter and Full Year Fiscal 2026 Results |
Globe Newswire |
08/12 |
16:05 |
| Perma-Fix Reports Second Quarter 2026 Results, Award of Hanford Master IDIQ Subcontract and Commencement of DFLAW Waste Receipts |
Globe Newswire |
08/12 |
16:05 |
| MaxCyte Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/12 |
16:05 |
| Forward Industries Reports Fiscal Third Quarter 2026 Financial and Operating Results |
Globe Newswire |
08/12 |
16:05 |
| Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China |
Globe Newswire |
08/12 |
16:05 |
| Enovix Reports Second Quarter 2026 Results |
Globe Newswire |
08/12 |
16:05 |
| NANO Nuclear Reports Q3 FY 2026 Financial Results and Provides Business Update |
Globe Newswire |
08/12 |
16:05 |
| BioStem Technologies Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/12 |
16:05 |
| Lumexa Imaging Announces Second Quarter 2026 Results |
Globe Newswire |
08/12 |
16:05 |
| Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
08/12 |
16:05 |
| Cerebras Systems Fast Inference Cloud Business Nearly Quadruples in Second Quarter 2026 |
Globe Newswire |
08/12 |
16:05 |
| Robinhood Markets, Inc. Reports July 2026 Operating Data |
Globe Newswire |
08/12 |
16:05 |
